MedQuist Expands Market Presence: Speech Recognition and Workflow Technology Selected for Eight-Facility Implementation
May 11 2011 - 4:00PM
MedQuist Holdings Inc. (Nasdaq:MEDH), a leading provider of
integrated clinical documentation solutions for the U.S. healthcare
system, today announced that it has been awarded a contract by
Anthelio Healthcare Solutions (formerly PHNS) of Dallas, Texas.
Anthelio will implement MedQuist's DocQment™ Enterprise Platform
(DEP), the industry-leading speech recognition and clinical
documentation workflow platform, in eight of its clients' hospitals
across five states for use by its medical transcriptionists. DEP
will replace existing technology currently in use by Anthelio,
providing unparalleled efficiency and productivity through more
automated clinical workflow management.
Anthelio, a provider of comprehensive healthcare information
technology services and business process solutions, selected
MedQuist based on previous experience with the robust speech
recognition capabilities and efficient workflow features built into
DEP. MedQuist-Anthelio clients, such as Detroit Medical Center,
already use DEP to create and manage clinical documentation across
their enterprise.
"Choosing the right technology partner can be complex and
challenging. MedQuist made the entire process simple and cost
effective," noted Dianne Summers, National Operations Director,
Anthelio Healthcare Solutions. "We've seen MedQuist's people and
platform in action and experienced the speed to value, innovation
and support they deliver. It's a winning combination that enables
us to quickly go to work for our customers."
In addition to directly providing healthcare facilities with
technology and services, MedQuist has a large number of B2B
relationships. With DEP as the backbone, companies supplying Health
Information Management (HIM) expertise and improvement solutions
provide results reporting, advanced speech, workflow and management
tools to better run their businesses. Efficiency, streamlined
workflow and cost reductions are just some of the benefits
healthcare institutions realize as a result of an integrated
MedQuist-partner relationship.
"Innovative technology helps healthcare leaders – from
physicians and finance to IT and health information management –
meet their revenue cycle, EHR meaningful use and patient care
goals," said Peter Masanotti, President and Chief Executive Officer
of MedQuist. "We're proud to expand our relationship with Anthelio
and look forward to bringing clinical transformation capabilities
to an extensive group of health organizations across the
country."
About MedQuist
MedQuist is a leading provider of medical transcription
services, and a leader in technology-enabled clinical documentation
workflow. MedQuist's enterprise solutions – including mobile voice
capture devices, speech recognition, Web-based workflow platforms,
and global network of medical editors – help healthcare facilities
improve patient care, increase physician satisfaction, and lower
operational costs. For more information, please visit
www.medquist.com.
About Anthelio Healthcare Solutions
Anthelio (formerly PHNS) provides comprehensive information
technology and business process services to hospitals, healthcare
providers and other businesses across the United States. Our
information technology services include application hosting,
co-location and managed services; electronic off-site data back-up
and data vaulting; business continuity solutions; disaster recovery
services and systems integration services. Our business process
services are focused primarily on hospitals, and include health
information management services (including medical record
management and storage, transcription, coding, release of
information and electronic medical record services) and revenue
cycle services. www.phns.com
"Safe Harbor" Statement under the U.S. Private Securities
Litigation Reform Act of 1995: Statements in this press release
regarding MedQuist's business that are not historical facts are
"forward-looking statements" that involve risks and uncertainties.
Actual outcomes and results may differ materially from what is
expressed or forecasted in forward-looking statements. As a result,
forward-looking statements speak only as of the date they were
made, and the Company undertakes no obligation to publicly update
or revise any forward-looking statements, whether as a result of
new information, future events or otherwise.
CONTACT: Thomas Mitchell
Director of Marketing
615-798-6630
tmitchell@medquist.com
Medx (CE) (USOTC:MEDH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medx (CE) (USOTC:MEDH)
Historical Stock Chart
From Jul 2023 to Jul 2024